17 filings
8-K
ABUS
Arbutus Biopharma Corp
23 Dec 19
Entry into a Material Definitive Agreement
4:09pm
8-K
ABUS
Arbutus Biopharma Corp
6 Nov 19
Arbutus Reports Third Quarter 2019 Financial Results and Provides Corporate Update
7:34am
8-K
ABUS
Arbutus Biopharma Corp
3 Oct 19
Other Events
4:16pm
8-K
ABUS
Arbutus Biopharma Corp
26 Aug 19
Other Events
4:14pm
8-K
ABUS
Arbutus Biopharma Corp
20 Aug 19
Departure of Directors or Certain Officers
4:09pm
8-K
tdvpp8v0
9 Aug 19
Other Events
4:05pm
8-K
4llgs
5 Aug 19
Arbutus Reports Second Quarter 2019 Financial Results and Provides Corporate Update
11:32am
8-K
n76rz
18 Jul 19
Other Events
4:05pm
8-K
e3zxu3zxz3pwmxvip
3 Jul 19
Entry into a Material Definitive Agreement
4:28pm
8-K
nl602tk4pr06myv53o
18 Jun 19
Former President of ViiV Healthcare North America joins Arbutus with decades of leadership experience in antivirals
4:00pm
8-K
affwlnfk
28 May 19
Submission of Matters to a Vote of Security Holders
4:53pm
8-K
5ato8svhpgx6n
20 May 19
Other Events
6:07am
8-K
5m333tgscp13l
6 May 19
Arbutus Reports First Quarter 2019 Financial Results and Provides Corporate Update
5:02pm
8-K
jc15o8ucfu8ezb
23 Apr 19
Changes in Registrant's Certifying Accountant
4:01pm
8-K
k31vq4y1
15 Mar 19
Departure of Directors or Certain Officers
2:03pm
8-K
hkmjhwjpji1os5p
7 Mar 19
Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
4:29pm
8-K
vbb y9bhzy
14 Feb 19
Results of Operations and Financial Condition
12:00am
- Prev
- 1
- Next